Positive activities for Asian American cancer patients and their caregivers
Official title: Positive Activities for Asian American Cancer Patients and Caregivers
Run by Fox Chase Cancer Center · NCT06782581 · Data updated 2026-11-12
This study is testing a new program that encourages positive activities for Asian American cancer patients and their caregivers to see if it helps improve their mental well-being.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 21 Years to 80 Years |
| Sex | All |
| Enrollment | 186 (estimated) |
| Sponsor | Fox Chase Cancer Center Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy, radiation |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | August 6, 2024 |
| Main results expected | January 15, 2027 |
| Study ends | February 15, 2027 |
| Registry record updated | December 31, 2025 |
| Trial ID | NCT06782581 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are Asian American adults aged 21-80 who are within one year of a cancer diagnosis or have stage 4 cancer and are currently undergoing treatment.
✕Probably not a fit
Patients with a life expectancy of less than six months or significant physical limitations that prevent participation may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to reduce the burden on caregivers of Asian American cancer patients by testing a new intervention that promotes positive activities designed to enhance patients' sense of autonomy, competence, and connectedness. The intervention includes two culturally tailored activities: household contribution and outside contribution, which have not been previously studied. The research will be conducted as a randomized controlled trial to evaluate the feasibility and efficacy of these activities in improving psychological well-being among participants. The study is grounded in self-determination theory and considers cultural challenges faced by Asian Americans.
Why it matters
Potential benefit: If successful, this intervention could significantly improve the psychological well-being of Asian American cancer patients and their caregivers.
How similar studies have gone: While this specific approach is novel, similar interventions focusing on positive activities have shown promise in enhancing well-being in other populations.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for Patients: 1. self-identifies as Asian American or Asian 2. males or females ages 21-80 years 3. within 2 years of any cancer diagnosis or stage 4 cancer diagnosis 4. actively undergoing surgery or systemic therapy (e.g., chemotherapy, radiation, immunotherapy) or within the past 6 months, 5. able to identify a caregiver (e.g., spouse) who lives in the same household or see at least 3 times per week 6. able to read, write, and speak English (i.e., English proficient; EP) or Mandarin/simplified Chinese. Exclusion Criteria for patients: 1. life expectancy less than 6 months in the opinion of the primary physician 2. inability to stand or walk on their own or other physical limitations that preclude them from participating (3+ on ECOG performance status), 3. major thought disorder (e.g., schizophrenia or bipolar \[patient records or self-disclosure\]). Inclusion Criteria for Caregivers: 1. identifies as Asian American or Asian, 2. patient considers them to be caregiver 3. English proficient or Mandarin Chinese proficient 4. access to computer/phone, internet, and web browser. Exclusion Criteria for Caregivers: 1. unwilling or unable to participate in the study for any reason, 2. under the age of 18.
Where it's running
-
Fox Chase Cancer Center - Philadelphia
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Lilian J. Shin-Cho, PhD
- Email: Lilian.Shin-Cho@fccc.edu
- Phone: 267-889-2209
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
4D MRI parameters linked to cardiovascular and cancer disease outcomes
This study tests whether 4D MRI measurements can predict how cardiovascular diseases and cancer will progress in adults undergoing routine cardiac MRI at a single Korean hospital.
-
Intratumoral injection of mechanically reprogrammed macrophage-derived exosomes for advanced solid tumors
This trial will test whether injecting mechanically reprogrammed macrophage-derived exosomes directly into tumors is safe and tolerable in adults 18–65 with advanced solid tumors who have no standard treatment options.
-
EMDR group program with optional individual EMDR for people with cancer
This project will try EMDR group therapy plus optional individual EMDR to reduce PTSD symptoms and psychological distress in people diagnosed with cancer.
-
KLN-1010 gene therapy for relapsed or refractory multiple myeloma
This Phase 1 trial will try KLN-1010, an in vivo CAR‑T gene therapy, to see if it is safe and can be given at a tolerable dose for people with relapsed or refractory multiple myeloma who have had at least three prior therapies.
-
Creating a network for precision oncology in central-southern Italy
This study is trying to create a network of labs in central-southern Italy to better understand cancer by improving testing methods and sharing information about tumors to help personalize treatment for patients.
-
Adaptive care for Chinese cancer survivors with insomnia
This study is testing whether a web-based therapy for insomnia or an online exercise program can help Chinese cancer survivors sleep better, and if those who still have trouble can benefit from more intensive face-to-face support.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.